259 related articles for article (PubMed ID: 18221039)
1. Endogenous angiogenesis inhibitors as therapeutic agents: historical perspective and future direction.
Dhanabal M; Sethuraman N
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):223-36. PubMed ID: 18221039
[TBL] [Abstract][Full Text] [Related]
2. Novel endogenous angiogenesis inhibitors and their therapeutic potential.
Rao N; Lee YF; Ge R
Acta Pharmacol Sin; 2015 Oct; 36(10):1177-90. PubMed ID: 26364800
[TBL] [Abstract][Full Text] [Related]
3. Review of selected patents for cancer therapy targeting tumor angiogenesis.
Kirstein MN; Moore MM; Dudek AZ
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of angiogenesis.
Zhang HT; Bicknell R
Mol Biotechnol; 2003 Oct; 25(2):185-200. PubMed ID: 14526126
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis: new targets for the development of anticancer chemotherapies.
Gourley M; Williamson JS
Curr Pharm Des; 2000 Mar; 6(4):417-39. PubMed ID: 10788590
[TBL] [Abstract][Full Text] [Related]
6. VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).
Peng FW; Liu DK; Zhang QW; Xu YG; Shi L
Expert Opin Ther Pat; 2017 Sep; 27(9):987-1004. PubMed ID: 28621580
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis inhibitors in cancer therapy.
Dredge K; Dalgleish AG; Marriott JB
Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis: an organizing principle for drug discovery?
Folkman J
Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
[TBL] [Abstract][Full Text] [Related]
9. A patent perspective of antiangiogenic agents.
Zhang J; Wang J; Li Y; Pan X; Qu J; Zhang J
Expert Opin Ther Pat; 2023 Dec; 33(12):821-840. PubMed ID: 38084667
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis inhibitors.
Kiselev SM; Lutsenko SV; Severin SE; Severin ES
Biochemistry (Mosc); 2003 May; 68(5):497-513. PubMed ID: 12882631
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in anti-angiogenic therapy of cancer.
Samant RS; Shevde LA
Oncotarget; 2011 Mar; 2(3):122-34. PubMed ID: 21399234
[TBL] [Abstract][Full Text] [Related]
14. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Biomed Pharmacother; 2023 Jul; 163():114806. PubMed ID: 37163782
[TBL] [Abstract][Full Text] [Related]
15. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
16. Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature.
Petrillo S; Tolosano E; Munaron L; Genova T
Recent Pat Anticancer Drug Discov; 2018; 13(4):422-427. PubMed ID: 29807523
[TBL] [Abstract][Full Text] [Related]
17. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.
Veeravagu A; Hsu AR; Cai W; Hou LC; Tse VC; Chen X
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):59-71. PubMed ID: 18221053
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic process as a therapeutic target in cancer.
Bridges EM; Harris AL
Biochem Pharmacol; 2011 May; 81(10):1183-91. PubMed ID: 21382350
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria as targets in angiogenesis inhibition.
Park D; Dilda PJ
Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]